Commentary · 8 Jun 2026
Conference abstractPublished 21 Nov 2013
Synergic roles of amyloid-β and tau oligomers in the development of neurotoxicity involved in Alzheimer�s disease progression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Accumulation of misfolded proteins in the neuronal cells results in dysregulation of calcium homeostasis and cellular dysfunction in peripheral and brain tissues. We have shown that the prolonged subcutaneous injection of casein amyloid aggregates, triggers beta amyloid accumulation in the mouse brain. This raises a question how an enrichment of one amyloid in the tissue leads to accumulation of another amyloid? We and others groups have shown that the amyloid oligomer on interaction with Ephrin-B2 receptor (Eph2) results in Eph2 depletion. Eph2 depletion would lead to aberrant NMDA signaling with increase in intracellular calcium [Ca2+]. More detailed in vivo and in vitro studies demonstrate that such up-regulation of calcium results in endoplasmic stress and inhibition of protein phosphatase 2A (PP2A). PP2A is involved in maintaining the tau hyper phosphoyrlation under control. Importantly, we observe PP2A is expressed abundantly in dendritic spines. Inhibition of PP2A would result in higher tau phosphorylation and decrease spine density. We have been developing specific ligands that would modify the toxic structure of oligomers to prevent Eph2 interactions. A class of novel amyloid-beta oligomer binding compounds are developed that would alter the oligomeric populations of A beta and tau converting them into non-toxic conformers thereby preventing their interaction with Eph2 receptors. These molecules also suppress aberrant NMDA receptor activation along with calcium elevation. We have shown toxic to nontoxic amyloid transitions are possible when oligomeric are interacting with small heat shock protein like alpha-crystalline. Thus, small molecules and small heat shock proteins could rescue the PP2A activity and significantly reduce the tau hyper phosphorylation and associated toxicity. This novel mechanistic pathway would help improve substantial and viable therapeutic intervention against AD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Jayakumar Rajadas”